Purchases and Sales Made in Q3 2022 in Tg Therapeutics, Inc. (TGTX)
This table provides information about the institutional ownership of Tg Therapeutics, Inc. (TGTX) during Q3 2022. The information is specifically focused on institutions that hold shares of TG THERAPEUTICS, INC..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 10, 2022
Q3 2022
|
M28 Capital Management LP
Stamford, CT |
SELL
|
- |
-387K- 53.35% |
$1.77M - $3.25M
|
339K
$10M
|
|
Nov 14, 2022
Q3 2022
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-397K- 90.98% |
$1.81M - $3.33M
|
39.3K
$1.16M
|
|
Nov 14, 2022
Q3 2022
|
Paradigm Biocapital Advisors LP
New York, NY |
SELL
|
- |
-459K- 23.37% |
$2.1M - $3.86M
|
1.51M
$44.5M
|
|
Nov 14, 2022
Q3 2022
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-513K- 42.25% |
$2.34M - $4.31M
|
701K
$20.7M
|
|
Nov 14, 2022
Q3 2022
|
683 Capital Management, LLC
New York, NY |
SELL
|
- |
-516K- 15.64% |
$2.36M - $4.33M
|
2.78M
$82.2M
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-996K- 20.09% |
$4.55M - $8.37M
|
3.96M
$117M
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-1M- 84.83% |
$4.58M - $8.42M
|
179K
$5.29M
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.52M- 80.16% |
$6.96M - $12.8M
|
377K
$11.1M
|
|
Nov 14, 2022
Q3 2022
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-1.65M- 73.94% |
$7.55M - $13.9M
|
582K
$17.2M
|
|
Nov 15, 2022
Q3 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-2.48M- 17.46% |
$11.4M - $20.9M
|
11.8M
$347M
|